These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 11026555

  • 21. Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype.
    Ala Y, Morin D, Mouillac B, Sabatier N, Vargas R, Cotte N, Déchaux M, Antignac C, Arthus MF, Lonergan M, Turner MS, Balestre MN, Alonso G, Hibert M, Barberis C, Hendy GN, Bichet DG, Jard S.
    J Am Soc Nephrol; 1998 Oct; 9(10):1861-72. PubMed ID: 9773787
    [Abstract] [Full Text] [Related]

  • 22. Two vasopressin type 2 receptor gene mutations R143P and delta V278 in patients with nephrogenic diabetes insipidus impair ligand binding of the receptor.
    Tsukaguchi H, Matsubara H, Mori Y, Yoshimasa Y, Yoshimasa T, Nakao K, Inada M.
    Biochem Biophys Res Commun; 1995 Jun 26; 211(3):967-77. PubMed ID: 7598729
    [Abstract] [Full Text] [Related]

  • 23. [Molecular biological studies on patients with nephrogenic diabetes insipidus].
    Szalai C, Molnár E, Sallay P, Czinner A.
    Orv Hetil; 1998 Apr 12; 139(15):883-7. PubMed ID: 9579101
    [Abstract] [Full Text] [Related]

  • 24. [Nephrogenic diabetes insipidus associated with mutations of vasopressin V2 receptors and aquaporin-2].
    Ishikawa SE.
    Nihon Rinsho; 2002 Feb 12; 60(2):350-5. PubMed ID: 11857925
    [Abstract] [Full Text] [Related]

  • 25. AVPR2 variants and V2 vasopressin receptor function in nephrogenic diabetes insipidus.
    Wildin RS, Cogdell DE, Valadez V.
    Kidney Int; 1998 Dec 12; 54(6):1909-22. PubMed ID: 9853256
    [Abstract] [Full Text] [Related]

  • 26. Functional characterization of vasopressin receptor 2 mutations causing partial and complete congenital nephrogenic diabetes insipidus in Thai families.
    Sahakitrungruang T, Tee MK, Rattanachartnarong N, Shotelersuk V, Suphapeetiporn K, Miller WL.
    Horm Res Paediatr; 2010 Dec 12; 73(5):349-54. PubMed ID: 20389105
    [Abstract] [Full Text] [Related]

  • 27. Nephrogenic diabetes insipidus.
    Morello JP, Bichet DG.
    Annu Rev Physiol; 2001 Dec 12; 63():607-30. PubMed ID: 11181969
    [Abstract] [Full Text] [Related]

  • 28. Altered agonist sensitivity of a mutant v2 receptor suggests a novel therapeutic strategy for nephrogenic diabetes insipidus.
    Erdélyi LS, Balla A, Patócs A, Tóth M, Várnai P, Hunyady L.
    Mol Endocrinol; 2014 May 12; 28(5):634-43. PubMed ID: 24628417
    [Abstract] [Full Text] [Related]

  • 29. Identification and characterization of a novel X-linked AVPR2 mutation causing partial nephrogenic diabetes insipidus: a case report and review of the literature.
    Neocleous V, Skordis N, Shammas C, Efstathiou E, Mastroyiannopoulos NP, Phylactou LA.
    Metabolism; 2012 Jul 12; 61(7):922-30. PubMed ID: 22386940
    [Abstract] [Full Text] [Related]

  • 30. [Nephrogenic diabetes insipidus].
    Evrard A, Lefebvre J, Vantyghem M.
    Ann Endocrinol (Paris); 1999 Dec 12; 60(6):457-64. PubMed ID: 10617799
    [Abstract] [Full Text] [Related]

  • 31. A low affinity vasopressin V2-receptor in inherited nephrogenic diabetes insipidus.
    Luzius H, Jans DA, Grünbaum EG, Moritz A, Rascher W, Fahrenholz F.
    J Recept Res; 1992 Dec 12; 12(3):351-68. PubMed ID: 1387165
    [Abstract] [Full Text] [Related]

  • 32. The effect of eight V2 vasopressin receptor mutations on stimulation of adenylyl cyclase and binding to vasopressin.
    Pan Y, Wilson P, Gitschier J.
    J Biol Chem; 1994 Dec 16; 269(50):31933-7. PubMed ID: 7527400
    [Abstract] [Full Text] [Related]

  • 33. V2R mutations and nephrogenic diabetes insipidus.
    Bichet DG.
    Prog Mol Biol Transl Sci; 2009 Dec 16; 89():15-29. PubMed ID: 20374732
    [Abstract] [Full Text] [Related]

  • 34. Nephrogenic diabetes insipidus.
    Bichet DG.
    Adv Chronic Kidney Dis; 2006 Apr 16; 13(2):96-104. PubMed ID: 16580609
    [Abstract] [Full Text] [Related]

  • 35. Lack of responsiveness to 1-desamino-D arginin vasopressin (desmopressin) in male patients with nephrogenic syndrome of inappropriate antidiuresis: from bench to bedside.
    Vandergheynst F, Pradier O, Beukinga I, Kornreich A, Vassart G, Decaux G.
    Eur J Clin Invest; 2012 Mar 16; 42(3):254-9. PubMed ID: 21834801
    [Abstract] [Full Text] [Related]

  • 36. Functional rescue of vasopressin V2 receptor mutants in MDCK cells by pharmacochaperones: relevance to therapy of nephrogenic diabetes insipidus.
    Robben JH, Sze M, Knoers NV, Deen PM.
    Am J Physiol Renal Physiol; 2007 Jan 16; 292(1):F253-60. PubMed ID: 16926443
    [Abstract] [Full Text] [Related]

  • 37. Vasopressin receptor mutations and nephrogenic diabetes insipidus.
    Birnbaumer M.
    Arch Med Res; 1999 Jan 16; 30(6):465-74. PubMed ID: 10714359
    [Abstract] [Full Text] [Related]

  • 38. Physiopathology and diagnosis of nephrogenic diabetes insipidus.
    Devuyst O.
    Ann Endocrinol (Paris); 2012 Apr 16; 73(2):128-9. PubMed ID: 22503803
    [Abstract] [Full Text] [Related]

  • 39. A novel AVPR2 splice site mutation leads to partial X-linked nephrogenic diabetes insipidus in two brothers.
    Schernthaner-Reiter MH, Adams D, Trivellin G, Ramnitz MS, Raygada M, Golas G, Faucz FR, Nilsson O, Nella AA, Dileepan K, Lodish M, Lee P, Tifft C, Markello T, Gahl W, Stratakis CA.
    Eur J Pediatr; 2016 May 16; 175(5):727-33. PubMed ID: 26795631
    [Abstract] [Full Text] [Related]

  • 40. Nephrogenic syndrome of inappropriate antidiuresis: a novel disorder in water balance in pediatric patients.
    Gitelman SE, Feldman BJ, Rosenthal SM.
    Am J Med; 2006 Jul 16; 119(7 Suppl 1):S54-8. PubMed ID: 16843086
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.